Overview
Kristy Hose is a Nurse Practitioner in Hagerstown, Maryland. Her top areas of expertise are HER2 Negative Breast Cancer and BRCA Positive Breast Cancer. Mrs. Hose is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
11110 Medical Campus Rd, Hagerstown, MD 21742
Medical Practices Of Antietam, LLC
Miranda Thomas is a Nurse Practitioner in Hagerstown, Maryland. Ms. Thomas is highly rated in 3 conditions, according to our data. Her top areas of expertise are Carbuncle, Folliculitis, Boils, and Non-Muscle Invasive Bladder Cancer. Ms. Thomas is currently accepting new patients.
Good Samaritan Physician Services
Doris Baskette is a Nurse Practitioner in York, Pennsylvania. Ms. Baskette is highly rated in 1 condition, according to our data. Her top area of expertise is Heart Failure with Preserved Ejection Fraction (HFpEF).
Peggy Bixler is a Nurse Practitioner in York, Pennsylvania. Ms. Bixler is highly rated in 1 condition, according to our data. Her top area of expertise is Heart Failure with Preserved Ejection Fraction (HFpEF).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BRCA Positive Breast CancerMrs. Hose isExperienced. Learn about BRCA Positive Breast Cancer.
- HER2 Negative Breast CancerMrs. Hose isExperienced. Learn about HER2 Negative Breast Cancer.